Timothy C Barabe, Director at Cartesian Therapeutics RNAC, reported a large exercise of company stock options on November 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback